| 发明名称 | Heterocyclic compound | ||
| 摘要 | The present invention relates to; wherein each symbol is as defined in the specification. The compound of the present invention has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of disease and condition mediated by increased RBP4. | ||
| 申请公布号 | US9487509(B2) | 申请公布日期 | 2016.11.08 |
| 申请号 | US201314055585 | 申请日期 | 2013.10.16 |
| 申请人 | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 发明人 | Kasai Shizuo;Kaku Tomohiro;Kamaura Masahiro |
| 分类号 | C07D205/04;C07D207/08;C07D207/12;C07D211/22;C07D211/44;C07D211/46;C07D211/78;C07D211/88;C07D401/06;C07D401/12;C07D403/06;C07D403/12;C07D413/06;C07D413/10;C07D413/12;C07D413/04;C07D417/06;C07D413/08;C07D417/04;C07D417/08;C07D417/10;C07D471/04;C07D495/04;C07D513/04 | 主分类号 | C07D205/04 |
| 代理机构 | Wenderoth, Lind & Ponack, L.L.P. | 代理人 | Wenderoth, Lind & Ponack, L.L.P. |
| 主权项 | 1. A compound represented by the formula wherein ring A is benzene optionally further substituted by 1 to 3 substituents selected from the group consisting of (1) a halogen atom, (2) an optionally halogenated C1-6 alkyl group and (3) an optionally halogenated C1-6 alkoxy group; R1 is an optionally substituted branched C3-6 alkyl group; X1 is O; X2 is a C1-3 alkylene group; ring B is piperidine; X3 is CO; and R2 is an acyl group, or a salt thereof. | ||
| 地址 | Osaka JP | ||